Binding of terbium and cisplatin to C13* human ovarian cancer cells using time-resolved terbium luminescence.

[1]  L. Schoeff.  Clinical Analyzers. General Chemistry , 1999 .

[2]  D. Paltoo,et al.  Effects of terbium on the cytotoxicity of cisplatin in FaDu human head and neck squamous cell carcinoma. , 1998, Cancer biochemistry biophysics.

[3]  P. Andrews,et al.  The effects of terbium on the cellular accumulation of cisplatin in MDA-MB-231 human breast tumor cells , 1996, Cancer Chemotherapy and Pharmacology.

[4]  D. A. Dougherty,et al.  Cation-π Interactions in Chemistry and Biology: A New View of Benzene, Phe, Tyr, and Trp , 1996, Science.

[5]  T. Veenstra,et al.  Identification of Metal-binding Sites in Rat Brain Calcium-binding Protein (*) , 1995, The Journal of Biological Chemistry.

[6]  D. Steel,et al.  Direct Kinetic Evidence for Triplet State Energy Transfer from Escherichia coli Alkaline Phosphatase Tryptophan 109 to Bound Terbium (*) , 1995, The Journal of Biological Chemistry.

[7]  A. Berchuck,et al.  Chemotherapy‐Induced Apoptosis in Epithelial Ovarian Cancers , 1995, Obstetrics and gynecology.

[8]  A. Haider,et al.  The effects of terbium on the accumulation of cisplatin in human ovarian cancer cells. , 1995, Biochimica et biophysica acta.

[9]  L. Milas,et al.  Kinetics of cisplatin‐induced apoptosis in murine mammary and ovarian adenocarcinomas , 1995, International journal of cancer.

[10]  D. Yin,et al.  Combination therapy with cisplatin and nifedipine inducing apoptosis in multidrug-resistant human glioblastoma cells. , 1995, Journal of neurosurgery.

[11]  C. O'Neill,et al.  Cisplatin induces apoptosis in a human ovarian carcinoma cell line without concomitant internucleosomal degradation of DNA. , 1994, Experimental cell research.

[12]  S. Howell,et al.  Cellular accumulation of the anticancer agent cisplatin: a review. , 1993, British Journal of Cancer.

[13]  S. Howell,et al.  Modulation of cisplatin cytotoxicity by permeabilization of the plasma membrane by digitonin in vitro. , 1993, Biochemical pharmacology.

[14]  R. Ozols,et al.  Mechanisms and modulation of resistance to chemotherapy in ovarian cancer , 1993, Cancer.

[15]  R. Canada.  Calcium receptor binding of cisplatin and terbium in human breast tumor cells after hyperthermia. , 1993, Radiation research.

[16]  N. Mulder,et al.  Modulation of cis-diamminedichloroplatinum(II) resistance: a review. , 1992, British Journal of Cancer.

[17]  J. Villafranca,et al.  Terbium(III) luminescence study of the spatial relationship of tryptophan residues to the two metal ion binding sites of Escherichia coli glutamine synthetase. , 1991, Biochemistry.

[18]  R. Carpentier,et al.  Physicochemical characteristics of the terbium-adriamycin complex and its effects on the sinus node automaticity. , 1991, Biochimica et biophysica acta.

[19]  J. Lansman.  Blockade of current through single calcium channels by trivalent lanthanide cations. Effect of ionic radius on the rates of ion entry and exit , 1990, The Journal of general physiology.

[20]  C. Evans.  Biochemistry of the Lanthanides , 1990, Biochemistry of the Elements.

[21]  K. Honn,et al.  In vivo characterization of combination antitumor chemotherapy with calcium channel blockers and cis-diamminedichloroplatinum(II). , 1989, Cancer research.

[22]  G. Fasman,et al.  Practical Handbook of Biochemistry and Molecular Biology , 1989 .

[23]  H. Simpkins,et al.  The interaction of platinum and anthrapyrazole antitumor drugs with mouse thymocytes studied by terbium fluorescence. , 1988, Biochimica et biophysica acta.

[24]  P. O’Hara.  LANTHANIDE IONS AS LUMINESCENT PROBES OF BIOMOLECULAR STRUCTURE , 1987, Photochemistry and photobiology.

[25]  R. Canada.  Terbium fluorescence studies of cisplatin binding to GH3/B6 pituitary tumor cells. , 1986, Biochimica et biophysica acta.

[26]  Bonnie F. Sloane,et al.  Cisplatin and nifedipine: synergistic cytotoxicity against murine solid tumors and their metastases. , 1986, Cancer letters.

[27]  S. Howell,et al.  Differential potentiation of alkylating and platinating agent cytotoxicity in human ovarian carcinoma cells by glutathione depletion. , 1985, Cancer research.

[28]  Barnett Rosenberg,et al.  Charles F. Kettring prize. Fundamental studies with cisplatin , 1985 .

[29]  R. Canada.  Terbium binding to neoplastic GH3 pituitary cells. , 1983, Biochemical and biophysical research communications.

[30]  R. Wallace,et al.  Calcium binding domains of calmodulin. Sequence of fill as determined with terbium luminescence. , 1982, The Journal of biological chemistry.

[31]  R. Martin,et al.  Lanthanide probes in biological systems: characterization of luminescence excitation spectra of terbium complexes with proteins. , 1981, Biophysical chemistry.

[32]  A. Snyder,et al.  Measurement of distance between fluorescent amino acid residues and metal ion binding sites. Quantitation of energy transfer between tryptophan and terbium(III) or europium(III) in thermolysin. , 1981, Biochemical and biophysical research communications.

[33]  W. Horrocks,et al.  Lanthanide ion luminescence probes. Measurement of distance between intrinsic protein fluorophores and bound metal ions: quantitation of energy transfer between tryptophan and terbium(III) or europium(III) in the calcium-binding protein parvalbumin , 1981 .

[34]  L. Stryer,et al.  Exchange interaction contribution to energy transfer between ions in the rapid-diffusion limit , 1981 .

[35]  R. Martin,et al.  Lanthanides as probes for calcium in biological systems , 1979, Quarterly Reviews of Biophysics.

[36]  C. Kittrell,et al.  Laser-induced lanthanide ion laminescence lifetime measurements by direct excitation of metal ion levels. A new class of structural probe for calcium-binding proteins and nucleic acids. , 1977, Journal of the American Chemical Society.

[37]  A. Sherry,et al.  A simple, one-step fluorometric method for determination of nanomolar concentrations of terbium. , 1976, Analytical biochemistry.

[38]  I. H. Segel.  Enzyme Kinetics: Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems , 1975 .

[39]  E. A. Burstein,et al.  FLUORESCENCE AND THE LOCATION OF TRYPTOPHAN RESIDUES IN PROTEIN MOLECULES , 1973, Photochemistry and photobiology.

[40]  Maurice W. Windsor,et al.  Luminescence and Energy Transfer in Solutions of Rare‐Earth Complexes. I. Enhancement of Fluorescence by Deuterium Substitution , 1965 .

[41]  R. E. Kellogg,et al.  Radiationless Intermolecular Energy Transfer. III. Determination of Phosphorescence Efficiencies , 1964 .

[42]  R. E. Kellogg,et al.  Radiationless Intermolecular Energy Transfer. II. Triplet→Singlet Transfer , 1964 .

[43]  P. Andrews,et al.  Mechanisms of acquired resistance to cisplatin. , 1994, Cancer treatment and research.

[44]  R. Canada.  Terbium luminescence studies of binding of adriamycin and cisplatin to tumorigenic cells , 1988 .

[45]  J. Lakowicz.  Principles of fluorescence spectroscopy , 1983 .

[46]  L. Stryer,et al.  Diffusion-enhanced fluorescence energy transfer. , 1982, Annual review of biophysics and bioengineering.

[47]  W. Horrocks,et al.  Lanthanide ion probes of structure in biology. Laser-induced luminescence decay constants provide a direct measure of the number of metal-coordinated water molecules , 1979 .

[48]  Raymond F. Chen,et al.  4 – Fluorescence of Proteins , 1969 .